The Montelukast Sodium Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the Montelukast Sodium market has seen robust growth recently. It is anticipated to increase from $3.86 billion in 2024 to $4.24 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.9%.
The Montelukast Sodium market is predicted to grow significantly in the future, with a projected size of $6.12 billion in 2029. The expected compound annual growth rate (CAGR) for this period is 9.6%.
Download Your Free Sample of the 2025 Montelukast Sodium Market Report and Uncover Key Trends Now!The drivers in the montelukast sodium market are:
• Rising instances of respiratory disorders
• Growth in the aging population
• Increasing levels of air pollution
• Expansion of awareness, education, and emerging markets
The montelukast sodium market covered in this report is segmented –
1) By Product: Crystal-like, Form-less Or Amorphous
2) By Dosage Form: Tablets, Oral Solutions
3) By Application: Bronchospasm, Allergic Coryza, Asthma, Urticaria, Other Applications
The trends in the montelukast sodium market are:
• Increased competition from generic brands is a significant emerging trend.
• There is a noted trend for a shift towards combination therapies.
• Expansion in emerging markets is driving future growth.
• The increasing focus on pediatric use and digital health solutions is reshaping the market.
The major players in the montelukast sodium market are:
• Pfizer Inc.
North America was the largest region in the montelukast sodium market in 2023